Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Philips Respironics develops, manufactures, and distributes respiratory care and sleep therapy devices, primarily for home use. It is a market leader in sleep and respiratory care, especially in CPAP and BiPAP machines for sleep apnea and non-invasive ventilators for chronic respiratory conditions. The company faced a major recall in 2021 related to hazardous foam in certain devices, but it remains active in the market, focusing on consumables and accessories post-recall[1][4][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Philips Respironics.